Earlier Detection.
Smarter Decisions.

Transforming scientific innovation into precision diagnostics and next-generation therapeutic solutions.

Earlier Detection.
Smarter Decisions.

Transforming scientific innovation into precision diagnostics and next-generation therapeutic solutions.

Explore Our Technologies

Explore Therapeutic Innovations

Partner With OneVita

Driven by Science. Focused on Impact.

NIAB Incubated

One Health Focused

Research Driven

Field Oriented

Technology Translation & Commercialization

About Us

About Us

Science That Moves From Discovery to Impact

OneVita Biosciences is a research-driven biotechnology company that transforms advances in molecular biology, aptamer engineering, biosensors, and biomolecular technologies into innovative diagnostic and therapeutic solutions.

Our expertise includes rapid diagnostics, antimicrobial susceptibility testing, molecular recognition, livestock health and nutrition, food and milk quality monitoring, and advanced biosensor development. Building on these capabilities, we are expanding our therapeutic research into areas such as aptamer-enabled *in vivo* CAR-T engineering, cellular immunotherapy, and novel antiviral platforms.

What We Do

Precision Diagnostics & Biosensors
Developing rapid, portable and affordable diagnostic technologies through advanced biosensors, molecular recognition systems and intelligent detection platforms.
Aptamer & Antibody Engineering
Discovering and engineering high-specificity DNA/RNA aptamers, antibodies and other molecular recognition elements for diagnostic, therapeutic and targeted biological applications.
Cellular Immunotherapy & In Vivo CAR-T
Exploring aptamer-enabled targeted delivery, immune-cell engineering and programmable cellular immunotherapy approaches to advance next-generation CAR-T technologies.
Antiviral Therapeutic Platforms
Developing research platforms based on aptamer-mediated viral recognition, viral inhibition, neutralisation and targeted delivery of antiviral therapeutics.
Antimicrobial Resistance & Infectious Disease Technologies
Creating innovative diagnostic and antimicrobial susceptibility testing solutions to support rapid pathogen detection, informed treatment decisions and antimicrobial stewardship.
One Health & Translational Biotechnology
Developing practical biotechnology solutions connecting human health, animal health, livestock productivity, food safety and emerging infectious disease challenges.

Pipeline

Beyond Diagnostics. Towards Next-Generation Therapeutics.

OneVita’s innovation pipeline extends beyond conventional diagnostics, encompassing a growing portfolio of biotechnology applications across animal health, human health and infectious disease management.

Our current and emerging areas of innovation include livestock nutrition, reproductive health, parasite control, rapid milk-quality assessment, antimicrobial susceptibility testing and next-generation One Health diagnostic platforms for human and food applications.

Building on our expertise in aptamer engineering, molecular recognition and biosensor technologies, we are expanding into emerging therapeutic research, including aptamer-enabled in vivo CAR-T engineering, cellular immunotherapy, targeted molecular delivery and innovative antiviral platforms.

Through an integrated approach to molecular discovery, technology development and translational research, we aim to advance a diverse pipeline of precision diagnostic and therapeutic solutions with potential for meaningful real-world impact.

Pipeline categories

Pipeline categories

Precision Diagnostics

Mastitis diagnostics, rapid antimicrobial susceptibility testing (AST), molecular biosensors, milk-quality assessment and One Health diagnostics for human and food applications.

Cellular Immunotherapy | Emerging R&D

Aptamer-enabled in vivo CAR-T engineering, targeted immune-cell delivery and programmable cellular therapeutic research.

Antiviral Therapeutics | Emerging R&D

Aptamer-based viral recognition, neutralisation, inhibition and targeted antiviral delivery.

Venom Diagnostics & Antivenom Development

Technology development
Aptamer- and antibody-based precision venom detection, toxin characterisation, and research and development of next-generation antivenom candidates.

Flagship Products

QuantM

Portable somatic cell counting technology designed to support early mastitis detection and dairy herd health monitoring.

Hour-Sense AST

Rapid antimicrobial sensitivity testing technology designed to support evidence-based veterinary treatment decisions.

Why Onevita?

One Health Perspective

We integrate human health, animal health and food safety through a connected approach to biotechnology innovation.

Advanced Molecular Biotechnology

We leverage aptamers, antibodies, nanobodies, biosensors and emerging molecular engineering technologies to develop next-generation diagnostic and therapeutic solutions.

Translational Innovation

We bridge scientific discovery and real-world applications, transforming promising research into practical diagnostic and therapeutic technologies.

Scalable by Design

We emphasise scientific validation, technology development, manufacturability and commercialisation to advance solutions with real-world potential.

Technology Platform

Molecular Science. Meaningful Innovation.

OneVita brings together molecular recognition, aptamer engineering, antibody and nanobody technologies, nucleic acid engineering and advanced biosensing to develop innovative diagnostic and therapeutic platforms.

Our integrated technology approach spans precision molecular detection, biomolecular engineering, targeted delivery systems and emerging cellular and antiviral therapeutic strategies. By combining molecular discovery with technological innovation, we aim to translate advanced biological research into next-generation solutions for human health, animal health and infectious diseases.

Aptamer Engineering

SELEX, DNA/RNA aptamer discovery, optimisation and functional molecular recognition.

Antibody & Nanobody Technologies

Molecular targeting, biomarker recognition and therapeutic candidate development.

Advanced Biosensors & Diagnostics

Portable diagnostic devices, electrochemical sensing and rapid molecular detection.

Targeted Molecular Delivery

Aptamer-functionalised delivery systems and targeted nucleic acid delivery research.

Next-Generation Therapeutics

Emerging research in in vivo CAR-T engineering, cellular immunotherapy and aptamer-based antiviral platforms.

Collaborate With Us

Let's Turn Scientific Innovation Into Real-World Solutions.

We welcome opportunities for research collaboration, technology development, validation and strategic partnerships.

Scroll to Top